Penn Medicine Penn Neuromuscular Symposium 2025

+ Target Audience: neurologists, physiatrists, and allied health professionals

+ Information:

The annual Penn Neuromuscular Symposium will discuss available and novel therapies for patients with neuromuscular disorders ranging from immuno-modulation to gene therapy. Experts will also present clinical cases selected from the Penn neuromuscular clinic to discuss where new diagnostic methods and treatments apply. The course will be interactive and attendees are encouraged to participate and exchange their experience and ask questions as they see fit. The Symposium will also explain how to enhance collaboration and knowledge exchange among neurologists and other healthcare professionals taking care of this unique patient population, which will also help facilitate enrollment in exciting clinical trials.

1. Describe novel treatment in myasthenia gravis
2. Discuss new methods to diagnose and treat neuropathy in Hereditary Transthyretin Amyloidosis.
3. Discuss different type of demyelinating neuropathies and how to manage them
4. Describe novel treatments for people with SMA and ALS
5. Discuss management of neuromuscular complications of vasculitis
6. Apply antibody testing in inflammatory myopathies and describe novel therapies for inflammatory myopathies
7. Discuss gene therapy for hereditary myopathies
8. Discuss application of car-T in autoimmune neuromuscular disorders

🧠 The Penn Neuromuscular Symposium 2025 is best for neurologists, physiatrists, and allied health professionals managing patients with neuromuscular disorders. It’s ideal for:

• Exploring novel therapies including immunomodulation and gene therapy
• Reviewing real-world clinical cases from Penn’s neuromuscular clinic
• Engaging in interactive discussions on diagnostics and treatment strategies

📅 Date: May 17, 2025 🕗 Time: 7:45 AM – 3:10 PM (ET) 📍 Location: Smilow Center for Translational Research, Philadelphia, PA

+ Topics:

Saturday, May 17, 2025